Pentwater Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Pentwater Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,082,920	Closed	-$58.1M	–	202
2019 Q3	$58.1M	Buy	+3,082,920	New	+$35.3M	0.91%	22

Pentwater Capital Management's ALDR Position: Q4 2019 in Review

Pentwater Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 3,082,920 shares — an estimated $58.1M sold.

Pentwater Capital Management first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $58.1M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Pentwater Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Pentwater Capital Management sold 3,082,920 Alder Biopharmaceuticals shares in Q4 2019, an estimated $58.1M.
Pentwater Capital Management first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Pentwater Capital Management's Alder Biopharmaceuticals position peaked at $58.1M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Pentwater Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.